Dr. Feder reflects on pediatric depression, seasonal sadness, and the myths around acetaminophen and autism. Plus, what’s next for research on leucovorin in autism—and why clinicians should balance caution with evidence-based optimism.

For years, autism care has centered on one model, but that’s changing. The American Academy of Child and Adolescent Psychiatry just redefined what evidence-based care really means. This shift could transform how we support children and families.

Working with young adults who are navigating ADHD is rarely straightforward. They’re often dealing with more than just distractibility or missed deadlines. There’s anxiety, identity shifts, life transitions, and sometimes a long history of feeling misunderstood. This isn’t about checking boxes on a symptom list, it’s about understanding how their brain, their environment, and their story all interact. Today, we’re going to unpack that. 

More teens are saying they can’t sleep because they’re worried about the environment. Today, we’re asking: How do we respond to climate anxiety without pathologizing it?  

Should you reach for an SNRI or stick with SSRIs when treating youth? This clinical update reviews the latest data on duloxetine and its peers, clarifies where SNRIs might fit in the treatment algorithm, and explores when—if ever—they’re worth trying in pediatric depression and anxiety.